Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +2 vs. Q3 2024
- Shares held
- 86.1M
- +6.65M (+8.4%) vs. Q3 2024
- Total value
- $477.2M
- −$185.8M (−28.0%) vs. Q3 2024
- New holders
- 38
- 67 more added
- Sold out
- 36
- 33 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighVista Strategies LLC | 130,966 | $725.6K | 0.27% | 00.0% | Unchanged |
| Graham Capital Management, L.P. | 132,999 | $736.8K | 0.02% | +119,661+897.1% | Added |
| UBS Oconnor LLC | 140,300 | $777.3K | 0.02% | +92,300+192.3% | Added |
| Exchange Traded Concepts, LLC | 142,919 | $791.8K | 0.02% | +36,363+34.1% | Added |
| Alyeska Investment Group, L.P. | 150,000 | $831.0K | 0.00% | 00.0% | Unchanged |
| Polymer Capital Management (HK) LTD | 177,000 | $980.6K | 0.17% | +153,000+637.5% | Added |
| Bank of New York Mellon Corp | 186,308 | $1.03M | 0.00% | +24,930+15.4% | Added |
| Bank of America Corp | 197,226 | $1.09M | 0.00% | +138,661+236.8% | Added |
| Infinitum Asset Management, LLC | 200,000 | $1.11M | 0.59% | +200,000 | New |
| Samsara BioCapital, LLC | 202,348 | $1.12M | 0.15% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 206,450 | $1.14M | 0.00% | +51,736+33.4% | Added |
| Wellington Management Group LLP | 222,514 | $1.23M | 0.00% | +449+0.2% | Added |
| BNP Paribas Arbitrage, SA | 224,265 | $1.24M | 0.00% | +224,265 | New |
| J. Goldman & Co LP | 235,831 | $1.31M | 0.05% | +31,890+15.6% | Added |
| LPL Financial LLC | 252,325 | $1.40M | 0.00% | +201,575+397.2% | Added |
| Trexquant Investment LP | 253,247 | $1.40M | 0.02% | −50,669−16.7% | Reduced |
| Ikarian Capital, LLC | 308,491 | $1.71M | 0.49% | −60.0% | Reduced |
| Woodline Partners LP | 311,612 | $1.73M | 0.01% | +10,388+3.4% | Added |
| Qube Research & Technologies Ltd | 314,389 | $1.74M | 0.00% | −142,550−31.2% | Reduced |
| Goldman Sachs Group Inc | 343,050 | $1.90M | 0.00% | −75,817−18.1% | Reduced |
| Salem Investment Counselors Inc | 346,725 | $1.92M | 0.06% | −29,875−7.9% | Reduced |
| Alliancebernstein L.P. | 362,359 | $2.01M | 0.00% | +117,783+48.2% | Added |
| Deutsche Bank AG | 398,379 | $2.21M | 0.00% | −144,467−26.6% | Reduced |
| UBS Group AG | 401,658 | $2.23M | 0.00% | +332,260+478.8% | Added |
| Acuta Capital Partners, LLC | 447,500 | $2.48M | 2.49% | −39,500−8.1% | Reduced |
| Integral Health Asset Management, LLC | 450,000 | $2.49M | 0.22% | +150,000+50.0% | Added |
| Altium Capital Management LP | 475,000 | $2.63M | 0.82% | +145,000+43.9% | Added |
| Northern Trust Corp | 591,171 | $3.28M | 0.00% | +127,296+27.4% | Added |
| Renaissance Technologies LLC | 623,134 | $3.45M | 0.01% | +143,634+30.0% | Added |
| Russell Investments Group, Ltd. | 628,395 | $3.48M | 0.00% | −116,292−15.6% | Reduced |
| Barclays PLC | 704,371 | $3.90M | 0.00% | +609,469+642.2% | Added |
| Boxer Capital Management, LLC | 752,000 | $4.17M | 0.35% | +752,000 | New |
| Marshall Wace, LLP | 803,336 | $4.45M | 0.01% | +698,578+666.8% | Added |
| Parkman Healthcare Partners LLC | 829,105 | $4.59M | 0.61% | +283,354+51.9% | Added |
| Norges Bank | 849,389 | $4.71M | 0.00% | +849,389 | New |
| Bellevue Group AG | 1,061,753 | $5.88M | 0.11% | +19,618+1.9% | Added |
| VR Adviser, LLC | 1,077,090 | $5.97M | 0.41% | −2,332,968−68.4% | Reduced |
| Point72 Asset Management, L.P. | 1,251,841 | $6.94M | 0.02% | −1,455,674−53.8% | Reduced |
| State Street Corp | 1,287,043 | $7.13M | 0.00% | +170,052+15.2% | Added |
| Dimensional Fund Advisors LP | 1,302,932 | $7.22M | 0.00% | +673,570+107.0% | Added |
| Price T Rowe Associates Inc | 1,504,238 | $8.34M | 0.00% | +28,559+1.9% | Added |
| Geode Capital Management, LLC | 1,516,478 | $8.40M | 0.00% | +308,999+25.6% | Added |
| Millennium Management LLC | 1,610,215 | $8.92M | 0.01% | +31,681+2.0% | Added |
| Driehaus Capital Management LLC | 1,661,846 | $9.21M | 0.08% | −429,955−20.6% | Reduced |
| Acorn Capital Advisors, LLC | 1,971,264 | $10.9M | 5.88% | +1,971,264 | New |
| Superstring Capital Management LP | 2,020,562 | $11.2M | 9.83% | +672,016+49.8% | Added |
| Candriam Luxembourg S.C.A. | 2,153,969 | $11.9M | 0.07% | +2,153,969 | New |
| Nuveen Asset Management, LLC | 2,633,918 | $14.6M | 0.00% | +617,009+30.6% | Added |
| Citadel Advisors LLC | 3,267,779 | $18.1M | 0.02% | −405,447−11.0% | Reduced |
| Morgan Stanley | 3,347,807 | $18.5M | 0.00% | +2,564,875+327.6% | Added |
| Vanguard Group Inc | 3,869,582 | $21.4M | 0.00% | +512,768+15.3% | Added |
| Schonfeld Strategic Advisors LLC | 4,751,506 | $26.3M | 0.17% | +1,461,680+44.4% | Added |
| Deep Track Capital, LP | 5,576,558 | $30.9M | 1.16% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,743,482 | $31.8M | 0.00% | +1,044,711+22.2% | Added |
| Vivo Capital, LLC | 6,895,746 | $38.2M | 4.28% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 7,562,971 | $41.9M | 0.87% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 8,142,500 | $45.1M | 3.41% | +1,918,956+30.8% | Added |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −2,133,872−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −752,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −449,321−100.0% | Sold out |
| Telemark Asset Management, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Bridger Management, LLC | 0 | $0 | 0.00% | −142,300−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −120,838−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −99,446−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −87,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −62,216−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −54,400−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −45,449−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −37,987−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −32,600−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −26,269−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −24,702−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,637−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −19,436−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −18,778−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −18,300−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −17,696−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −15,682−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −11,172−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −10,316−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,263−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −9,316−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,690−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −1,110−100.0% | Sold out |
| Prestige Wealth Management Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Alera Investment Advisors, LLC | – | – | – | – | Not filed |